HUGE News and Press, FSD Pharma Inc. From 03/09/20

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced receipt of approval from the Ethics Committee of the Alfred Hospital, part of the Alfred Health group of hospitals serving the state of Victoria in Australia, to initiate a P...

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2020) - FSD Pharma Inc. ( CSE:  HUGE ) ( NASDAQ:  HUGE ) CEO and Executive Co-Chairman, Dr. Raza Bokhari speaks about the company's worldwide license of a naturally occurring fatty acid. If you cannot view the video...

Vancouver, British Columbia--(Newsfile Corp. - February 24, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a specialty, biotech pharmaceutical R&D company focused on developing, over time, a robust pipeline of FDA approved synthetic compounds targeting the endocannabinoid ...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced the sale of its 12% equity interest in Cannara Biotech Inc. (CSE: LOVE) ("Cannara") to a consortium of buyers for cash proceeds of more than $7.7 million (the "Share Sale Tra...

Phoenix, Arizona--(Newsfile Corp. - February 11, 2020) - The Stock Day Podcast welcomed FSD Pharma (NASDAQ: HUGE) (the Company"), a specialty biotech pharmaceutical R&D company focused on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabino...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company") announces that Raza Bokhari, MD, Executive Co-Chairman and Chief Executive Officer, accompanied by FSD Pharma Biosciences leadership, will be participating in the 22 nd Annual BIO CEO & Investor conf...

FSD Pharma and Solarvest Enhance Commitment to CBD Research Project Canada NewsWire TORONTO, Feb. 4, 2020 TORONTO , Feb. 4, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)  (" FSD Pharma ") and Solarvest BioEnergy Inc. (TSX-V: SVS) (" Solarve...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced that it has appointed Larry Kaiser, MD, FACS to its Board of Directors, effective immediately. Dr. Kaiser will also continue to serve as the Chairman of FSD Pharma’s S...

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the "Company") is pleased to announce that Executive Co-Chairman and CEO Dr. Raza Bokhari, along with the founders, members of the Company’s Board of Directors, members of the leadership team, early in...

Delta, Kelowna, BC - January 10, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight fr...